Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02942771 · ClinicalTrials.gov registry record · Phase 1
A MAD Study of TT301/MW189 in Healthy Volunteers
A Phase 1 study of Healthy Adult Volunteers, sponsored by Linda Van Eldik.
- Completed
- Registry status
- Phase 1
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT02942771 is a Phase 1 study of Healthy Adult Volunteers that has completed, run by Linda Van Eldik. The registered enrollment target is 35 participants, above the 15-participant average among 4 other Healthy Adult Volunteers trials with a reported enrollment target (133% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02942771, a Phase 1 study of Healthy Adult Volunteers, has completed, sponsored by Linda Van Eldik.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this Study is to find out whether an investigational drug is safe and well tolerated. MW189 is being studied as a possible short-term treatment for people with different types of brain injury. MW189 has previously been given to healthy human volunteers as a single dose, and there were no significant problems or bad effects in people who received the Study drug. However, before it can be tested in people with brain injury, it is important to test MW189 in healthy volunteers when given multiple doses.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG 0.075mg/kg TT301/MW189
- DRUG 0.15mg/kg TT301MW189
- DRUG 0.25mg/kg TT301/MW189
- DRUG 0.30mg/kg TT301/MW189
Study Locations (1)
North Carolina
- Duke Clinical Research Unit 40 Duke Medicine Circle - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2017-03-20 |
| Est. Completion | 2018-06-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02942771
The ClinicalTrials.gov registry entry for NCT02942771 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 15-participant average among 4 other Healthy Adult Volunteers trials with a reported enrollment target (133% higher). The listed sponsor is Linda Van Eldik, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Adult Volunteers appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.
NCT02942771 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT02942771 about?
NCT02942771 is a clinical study titled "A MAD Study of TT301/MW189 in Healthy Volunteers". The purpose of this Study is to find out whether an investigational drug is safe and well tolerated. MW189 is being studied as a possible short-term treatment for people with different types of brain injury. MW189 has previously been given to healthy human volunteers as a single dose, and there were...
What is the current status of trial NCT02942771?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 35 participants. The study started on 2017-03-20. Estimated completion is 2018-06-04.
What conditions does trial NCT02942771 study?
This clinical trial studies the following conditions: Healthy Adult Volunteers.
What interventions are being tested in trial NCT02942771?
The interventions under investigation include: Placebo (DRUG), 0.075mg/kg TT301/MW189 (DRUG), 0.15mg/kg TT301MW189 (DRUG), 0.25mg/kg TT301/MW189 (DRUG), 0.30mg/kg TT301/MW189 (DRUG).
Who is sponsoring clinical trial NCT02942771?
This trial is sponsored by Linda Van Eldik, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02942771 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Adult Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult Subjects
COMPLETED · Phase 1
-
Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-986120 in Healthy Subjects and the Effects of Co-Administration of Midazolam and BMS-986120
COMPLETED · Phase 1
-
4-methylpyrazole and Acetaminophen Metabolism
COMPLETED · Early Phase 1
-
Assessment of End Expiratory Lung Volumes in Healthy Subjects Using High Flow Oxygen (Vapotherm®)
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.